A Study of the Trabecular Micro-Bypass Stent in Combination With Cataract Surgery in Open Angle Glaucoma Subjects.

NCT ID: NCT00326014

Last Updated: 2015-06-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

58 participants

Study Classification

INTERVENTIONAL

Study Start Date

2003-04-30

Study Completion Date

2009-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the safety and efficacy of a new trabecular bypass that is implanted in conjunction with cataract surgery in open angle glaucoma subjects.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Glaukos Corporation conducted a clinical research study at multiple investigational sites within Europe (8)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Open-Angle Glaucoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A

Group Type EXPERIMENTAL

iStent

Intervention Type DEVICE

Glaucoma Surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

iStent

Glaucoma Surgery

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Glaukos iStent

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed with primary open-angle glaucoma (POAG)
* Subject on at least one glaucoma medication
* Patient requiring cataract surgery and an intraocular lens implantation

Exclusion Criteria

* Prior glaucoma procedures (eg trabeculectomy, viscocanalostomy, ALT, SLT, shunt implant, collagen implant, cyclo destructive procedures etc)
* Angle closure glaucoma
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Glaukos Corporation

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Head of clinical Affairs

Role: STUDY_DIRECTOR

Glaukos Corporation

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Klinik Vincentinum

Augsburg, , Germany

Site Status

Universitats Augenklinik

Freiburg im Breisgau, , Germany

Site Status

Rotkreuz Krankenhaus

München, , Germany

Site Status

Klinikum Neubrandenburg

Neubrandenburg, , Germany

Site Status

Augenaerztliche Gemeinschaftspraxis

Weinheim, , Germany

Site Status

Clinico San Carlos

Madrid, , Spain

Site Status

Instituto Oftalmológico de Aragón

Zaragoza, , Spain

Site Status

Augenklinik Kantonsspital

Winterthur, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany Spain Switzerland

References

Explore related publications, articles, or registry entries linked to this study.

Spiegel D, Wetzel W, Neuhann T, Stuermer J, Hoeh H, Garcia-Feijoo J, Martinez-De-La-Casa JM, Garcia-Sanchez J. Coexistent primary open-angle glaucoma and cataract: interim analysis of a trabecular micro-bypass stent and concurrent cataract surgery. Eur J Ophthalmol. 2009 May-Jun;19(3):393-9. doi: 10.1177/112067210901900311.

Reference Type BACKGROUND
PMID: 19396784 (View on PubMed)

Spiegel D, Garcia-Feijoo J, Garcia-Sanchez J, Lamielle H. Coexistent primary open-angle glaucoma and cataract: preliminary analysis of treatment by cataract surgery and the iStent trabecular micro-bypass stent. Adv Ther. 2008 May;25(5):453-64. doi: 10.1007/s12325-008-0062-6.

Reference Type BACKGROUND
PMID: 18594784 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GC-002

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.